Company Overview of Obagi Medical Products, Inc.
Obagi Medical Products, Inc., a specialty pharmaceutical company, develops, markets, and sells topical aesthetic and therapeutic prescription skin care systems. It offers Obagi Nu-Derm System, which include prescription and OTC drugs that are used for the treatment of fine lines, wrinkles, acne, photo damage, hyperpigmentation, melasma, laxity, and skin sallowness; Obagi Condition and Enhance Systems used before and after surgical and non-surgical cosmetic procedures; Obagi-C Rx System that comprises Vitamin C with 4% hydroquinone system; and Professional-C products consisting of Vitamin C serums. The company also provides ELASTIderm Eye and Décolletage, which increases the elasticity and sk...
50 Technology Drive
Irvine, CA 92618
Founded in 1988
Key Executives for Obagi Medical Products, Inc.
Chief Executive Officer, President and Director
Vice President of Manufacturing & Technical Services
Vice President of International Sales & Marketing
Vice President of Regulatory Affairs & QA
Compensation as of Fiscal Year 2016.
Obagi Medical Products, Inc. Key Developments
Valeant Reportedly Works With Morgan Stanley To Sell Solta Medical And Obagi Medical
Jun 14 16
Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has engaged Morgan Stanley for the sale of Obagi Medical Products, Inc. and Solta Medical, Inc. to raise cash to reduce debt, according to people familiar with the matter. The two sale could fetch as much as $500 million and the sale process could start as early as this week, the people added. Bloomberg added that representatives at Valeant and Morgan Stanley declined to comment.
Valeant Considering Disposal Of Obagi Medical Products and Provenge
May 17 16
Valeant Pharmaceuticals International, Inc. (NYSE:VRX) is considering disposal Of Obagi Medical Products, Inc. and Provenge it acquired last year. Valeant Pharmaceuticals divestitures could raise as much as $1 billion and attract other drugmakers with an interest in those areas.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries